avelumab,Pembrolizumab,cetuximab,bevacizumab
merck,pfizer,eli lilly
['congrat', 'avelumab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
congrats to pr julien taieb for the samco phase ii trial in 2nd line #crc patients population at . trial sponsored by . even if the curves are crossing, in favor of avelumab. to be followed ! 
Fédération francophone de cancérologie digestive. Nos missions : la recherche et la formation. Essais thérapeutiques pour faire progresser les traitements.